ADPT
Price
$15.17
Change
+$1.42 (+10.33%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.1B
90 days until earnings call
Intraday BUY SELL Signals
ASMB
Price
$38.08
Change
+$2.19 (+6.10%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
564.99M
Intraday BUY SELL Signals
Interact to see
Advertisement

ADPT vs ASMB

Header iconADPT vs ASMB Comparison
Open Charts ADPT vs ASMBBanner chart's image
Adaptive Biotechnologies
Price$15.17
Change+$1.42 (+10.33%)
Volume$62.79K
Capitalization2.1B
Assembly Biosciences
Price$38.08
Change+$2.19 (+6.10%)
Volume$2.71K
Capitalization564.99M
ADPT vs ASMB Comparison Chart in %
ADPT
Daily Signal:
Gain/Loss:
ASMB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADPT vs. ASMB commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and ASMB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ADPT: $13.75 vs. ASMB: $35.72)
Brand notoriety: ADPT: Notable vs. ASMB: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 106% vs. ASMB: 65%
Market capitalization -- ADPT: $2.1B vs. ASMB: $564.99M
ADPT [@Biotechnology] is valued at $2.1B. ASMB’s [@Biotechnology] market capitalization is $564.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileASMB’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • ASMB’s FA Score: 1 green, 4 red.
According to our system of comparison, ASMB is a better buy in the long-term than ADPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while ASMB’s TA Score has 2 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 6 bearish.
  • ASMB’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both ADPT and ASMB are a bad buy in the short-term.

Price Growth

ADPT (@Biotechnology) experienced а -5.37% price change this week, while ASMB (@Biotechnology) price change was +7.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.02%. For the same industry, the average monthly price growth was -5.52%, and the average quarterly price growth was +65.24%.

Reported Earning Dates

ADPT is expected to report earnings on Feb 17, 2026.

Industries' Descriptions

@Biotechnology (-2.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($2.1B) has a higher market cap than ASMB($565M). ADPT (129.358) and ASMB (126.362) have similar YTD gains . ASMB has higher annual earnings (EBITDA): -43.39M vs. ADPT (-91.22M). ADPT has more cash in the bank: 198M vs. ASMB (75M). ASMB has less debt than ADPT: ASMB (2.88M) vs ADPT (84.4M). ADPT has higher revenues than ASMB: ADPT (205M) vs ASMB (33.2M).
ADPTASMBADPT / ASMB
Capitalization2.1B565M372%
EBITDA-91.22M-43.39M210%
Gain YTD129.358126.362102%
P/E RatioN/AN/A-
Revenue205M33.2M617%
Total Cash198M75M264%
Total Debt84.4M2.88M2,926%
FUNDAMENTALS RATINGS
ADPT vs ASMB: Fundamental Ratings
ADPT
ASMB
OUTLOOK RATING
1..100
5520
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
3935
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASMB's Valuation (29) in the Pharmaceuticals Other industry is in the same range as ADPT (52) in the Hospital Or Nursing Management industry. This means that ASMB’s stock grew similarly to ADPT’s over the last 12 months.

ASMB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that ASMB’s stock grew similarly to ADPT’s over the last 12 months.

ADPT's SMR Rating (96) in the Hospital Or Nursing Management industry is in the same range as ASMB (99) in the Pharmaceuticals Other industry. This means that ADPT’s stock grew similarly to ASMB’s over the last 12 months.

ASMB's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as ADPT (39) in the Hospital Or Nursing Management industry. This means that ASMB’s stock grew similarly to ADPT’s over the last 12 months.

ASMB's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that ASMB’s stock grew similarly to ADPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTASMB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signal:
Gain/Loss:
ASMB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OISVX13.890.08
+0.58%
Optimum Small-Mid Cap Value Instl
TQMIX18.27N/A
N/A
AMG TimesSquare Mid Cap Growth I
MSACX20.70N/A
N/A
Morgan Stanley Inst Passport ovrs eq I
TRLIX24.84N/A
N/A
Nuveen Large Cap Value R6
ALTEX11.94-0.08
-0.67%
Firsthand Alternative Energy

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+0.29%
AXON - ADPT
56%
Loosely correlated
-1.74%
VCYT - ADPT
54%
Loosely correlated
-1.35%
ARRY - ADPT
50%
Loosely correlated
-3.82%
BEAM - ADPT
49%
Loosely correlated
-0.36%
DNA - ADPT
45%
Loosely correlated
+0.64%
More

ASMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with SPRC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASMB
1D Price
Change %
ASMB100%
-1.68%
SPRC - ASMB
45%
Loosely correlated
-3.64%
KYTX - ASMB
34%
Loosely correlated
+9.50%
ADPT - ASMB
34%
Loosely correlated
+0.29%
RGNX - ASMB
33%
Loosely correlated
+0.94%
ORMP - ASMB
33%
Loosely correlated
+6.84%
More